New Hope Network is part of the Informa Markets Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

KSM-66 ashwagandha scores accolades at trade shows

KSM-66 ashwagandha scores accolades at trade shows
Ixoreal Biomed's ingredient was named Innovative Ingredient of the Year at the Asian trade show Panacea and was a finalist for the Best Botanical award at Engredea.

This past spring KSM-66 Advanced Ashwagandha received recognition at two of the nutrition industry's largest trade shows. Its first award as "Innovative Ingredient of the Year" was given at Panacea, South Asia's largest trade show and conference for nutrition products held in Mumbai, India. KSM-66 was further recognized at Engredea as part of the Expo West trade show in Anaheim, California, as a finalist for the "Best Botanical" award. Both award selection processes included reviews by key industry experts and influencers.

"We're excited that industry leaders have validated our dedication for introducing KSM-66 on a science-based, sustainable platform," said Kartikeya Baldwa, director for Ixoreal Biomed. "KSM-66 has been clinically studied in humans and offers distinct advantages such as its high potency and consistency."

Ixoreal Biomed is the only ashwagandha manufacturer in the world to own the entire value chain for producing the extract. Ixoreal Biomed has its own farms, production facilities, testing laboratories, research and distribution. As a result, Ixoreal Biomed can ensure batch-to-batch consistency and maintain a cost-effective, reliable supply base.

KSM-66 has been evaluated in five scientific studies with an additional two studies ongoing. These studies define the role of KSM-66 as an adaptogen for healthy stress management where it exhibits a normalizing effect against common physical, chemical and biological stressors. The first of these studies will be published by the Indian Journal of Psychiatry and investigated the efficacy of KSM-66 in 64 healthy adults who were under stress. The remaining studies examined KSM-66 and its stress-reducing properties related to energy, infertility, immunity, longevity, cognitive function and physical performance. 


Hide comments


  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.